CAT
Caterpillar Inc.
CAT offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
PKE
Park Aerospace Corp.
PKE has the edge over CAT overall, supported by stronger valuation and stronger fundamentals.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
PKE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
PKE's revenue, profitability, cash flow and balance sheet are all currently healthy.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over PKE in the historical PE scenario, which offers more potential upside but is not a forecast.
PKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 27x | $19.70 | -20% |
| Forward | 33x | $24.70 | — |
| Current | 34x | $24.70 | — |
| Fair | 37x | $26.48 | +7.2% |
| Expensive | 54x | $38.58 | +56% |
Historical ranges are pointers, not guarantees.
PKE's PE is in its fair range at 34x. If earnings grow as analysts expect, today's price would be 33x next year's earnings.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
CAT has the edge over PKE on the outlook, with more favorable valuation expectations.
PKE Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Strong growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for PKE, with profitability improving.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT earned $25.48 per share over the past year, up 31% from the year before.
PKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.75 | +4.2% |
| Q3 2026 | $0.72 | +100% |
| Q2 2026 | $0.63 | +85% |
| Q1 2026 | $0.56 | +93% |
| Q4 2025 | $0.43 | +19% |
| Q3 2025 | $0.36 | +5.9% |
| Q2 2025 | $0.34 | +3% |
| Q1 2025 | $0.29 | -22% |
| Q4 2024 | $0.36 | -23% |
PKE has the edge over CAT on earnings, with more consistent year-over-year improvement.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT's revenue has grown year over year for five quarters in a row: $20.7B last quarter, up 17% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT's operating margin was 20% last quarter, up 3.1 points from the same quarter a year ago.
PKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.8M | +27% |
| Q2 2026 | $18.3M | +19% |
| Q1 2026 | $24.2M | +43% |
| Q4 2025 | $17.3M | +20% |
| Q3 2025 | $16.4M | -2% |
| Q2 2025 | $15.4M | +10% |
| Q1 2025 | $16.9M | +3.7% |
| Q4 2024 | $14.4M | +24% |
PKE has the edge over CAT on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +5.4 points |
| Q2 2026 | 22% | +6.2 points |
| Q1 2026 | 19% | +2.2 points |
| Q4 2025 | 21% | +8.2 points |
| Q3 2025 | 17% | +1.7 points |
| Q2 2025 | 16% | +0.8 points |
| Q1 2025 | 17% | +1.1 points |
| Q4 2024 | 13% | +1.1 points |
PKE has the edge over CAT on profitability, with a higher operating margin.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT generated $11.3B in free cash flow over the past year, up 26% from the year before.
PKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.8M | +$494K |
| Q2 2026 | $2.6M | +135% |
| Q1 2026 | $6.4M | +1788% |
| Q4 2025 | $4.3M | +60% |
| Q3 2025 | -$2.3M | -284% |
| Q2 2025 | $1.1M | +$1.5M |
| Q1 2025 | $338K | -93% |
| Q4 2024 | $2.7M | +62% |
PKE has the edge over CAT on cash flow, with more consistent year-over-year improvement.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over PKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
PKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +692K shares |
| 1 year | +9.7% | +1.9M shares |
| 3 years | +6.8% | +1.4M shares |
| 5 years | +5.8% | +1.2M shares |
| Available history | +6.3% | +1.3M shares |
PKE has 22M diluted shares, up 9.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.2M |
| Q1 2025 | — |
| Q4 2024 | $2.4M |
PKE hasn't bought back shares in the past year.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
PKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -5.2x | Net Cash |
| Q2 2026 | -4.7x | Net Cash |
| Q1 2026 | -5.1x | Net Cash |
| Q4 2025 | -3.7x | Net Cash |
| Q3 2025 | -2.5x | Net Cash |
| Q2 2025 | -1.8x | Net Cash |
| Q1 2025 | -1.9x | Net Cash |
| Q4 2024 | -1.2x | Net Cash |
PKE has the edge over CAT on leverage, with a lower net debt burden relative to earnings.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
PKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.5 | Neutral |
| Stochastic | 8.8 | Oversold |
PKE's weekly RSI is 38 (neutral) and its Stochastic is 9 (oversold).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT has the edge over PKE on valuation relative to its sector.
PKE PE vs Industrials Sector
| Metric | PKE | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 24x | 43% above |
| PE % | 41 | 58 | 17 pts below |
PKE is trading at 34x earnings, a 43% premium to the Industrials sector's median of 24x.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
PKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $26.6 | 7.1% below |
| 20 week MA | $31.0 | 20% below |
| 50 week MA | $29.2 | 15% below |
| 100 week MA | $22.6 | 9.5% above |
| 200 week MA | $18.4 | 34% above |
PKE has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 34% above its 200-week average.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
PKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $16.2 | $13.2 | -18% |
| 2021 | $13.2 | $13.2 | +0.1% |
| 2022 | $13.2 | $11.6 | -13% |
| 2023 | $11.6 | $14.7 | +27% |
| 2024 | $14.7 | $14.5 | -1.2% |
| 2025 | $14.5 | $21.4 | +47% |
| 2026 YTD | $21.4 | $24.7 | +16% |
PKE has the edge over CAT on returns for 2026, with the stronger performance.